Myomo, Inc. Reports Third Quarter 2017 Results
CAMBRIDGE, Mass., November 6, 2017 – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a commercial stage medical robotics company, today reports its financial results for the three and nine months ended September 30, 2017. Read more.
Myomo Enters Canadian Market
Ottobock to Distribute MyoPro® to Orthotics and Prosthetics Practices Throughout Country CAMBRIDGE, Mass., November 03, 2017 – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a commercial stage medical robotics company, today announced that its Application for a Canadian Medical Device License has been approved by Health Canada. With the license, Myomo and its […]
Myomo, Inc. Launches Awareness Program for Veterans of the U.S. Armed Forces
MyoPro® for Veterans is Designed to Broaden MyoPro Accessibility to the Many Veterans Who May Benefit. CAMBRIDGE, Mass., October 17, 2017 – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a commercial stage medical device company, today announced the launch of MyoPro For Veterans, a strategic awareness program that broadens accessibility of MyoPro powered […]
Myomo, Inc. Reports Second Quarter 2017 Results
CAMBRIDGE, Mass., August 14, 2017 – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a commercial stage medical robotics company, today reports its financial results for the three and six months ended June 30, 2017. Read more.
Myomo, Inc. Obtains CE Mark Approval for MyoPro®
Myomo, Inc. Obtains CE Mark Approval for MyoPro® Enables Company to Start Providing Devices in Europe CAMBRIDGE, Mass., July 31, 2017 – Myomo, Inc. (NYSE MKT: MYO) (“Myomo” or the “Company”), a commercial stage medical robotics company, today announced that it has obtained CE Mark approval for commercial sale of its next-generation MyoPro myoelectric arm orthosis […]
Myomo Expands Management Team
Myomo Expands Management Team to Accelerate Commercialization of MyoPro® Powered Orthosis CAMBRIDGE, Mass., July 25, 2017 – Myomo®, Inc. (NSYE MKT: MYO), a commercial stage medical robotics company, today announced the expansion of its management team with three new full-time positions in medical affairs, sales and marketing. The expansion marks the company’s accelerated commercialization of […]
Myomo, Inc. Introduces Center of Excellence Program
Nationwide Roster of Top O&P Practices Supports MyoPro® Powered Orthosis Nationwide Roster of Top O&P Practices Supports MyoPro® Powered Orthosis Cambridge, MA., July 12, 2017 – Myomo®, Inc. (NSYE MKT: MYO) (“Myomo” or the “Company”), a commercial stage medical robotics company, today announced the launch of its Center of Excellence (CoE) program, which recognizes top […]
Myomo, Inc. Launches MyoPro® 2
Powered Arm Orthosis Features Interchangeable, Extended-life Rechargeable Batteries Myomo, Inc. (NSYE MKT: MYO) today announced the launch of its next-generation MyoPro® myoelectric arm orthosis (powered brace), the only lightweight wearable device that can restore function in the paralyzed or weakened arms and hands of individuals who have suffered a stroke, spinal cord or nerve injury, […]
Myomo, Inc. Trades On The New York Stock Exchange MKT
Myomo, Inc. today announces that following the close of its initial public offering, its common shares will begin trading on the NYSE. Read press release.
Myomo, Inc. Completes Historic Initial Public Offering
First company to go public on the NYSE MKT under JOBS Act Regulation A+ Cambridge, MA., June 9, 2017 – Myomo, Inc. (“Myomo” or the “Company”), a commercial stage medical robotics company, today announced the completion of its initial public offering (IPO) under SEC Regulation A+, raising $5.0 Million through the sale of 665,498 shares […]